Akifumi Matsuyama

Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages

Noriyuki Ouchi, Shinji Kihara, Yukio Arita et al. · Circulation · 2001 · 1.3K citations

Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages

Takafumi Yokota, Kenji Oritani, Isao Takahashi et al. · Blood · 2000 · 1.3K citations

Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM: report of a case

Yoshiki Sawa, Shigeru Miyagawa, Taichi Sakaguchi et al. · Surgery Today · 2011 · 320 citations

Mechanobiology, Tissue Engineering, Regenerative Medicine +13

A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19

Yohei Doi, Masaya Hibino, Ryota Hase et al. · Antimicrobial Agents and Chemotherapy · 2020 · 231 citations · Full text

Open-label Trial, Late Favipiravir Therapy, Clinical Infectious Disease +14

Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction

Naoki Okumura, Yuji Sakamoto, Keita Fujii et al. · Scientific Reports · 2016 · 178 citations · Full text